Trinity Capital Inc. (TRIN) – PRNewswire
-
Trinity Capital Inc. Provides Details for First Quarter 2024 Financial Results and Conference Call
-
Parafin Secures $125 Million Warehouse Facility from Silicon Valley Bank and Trinity Capital Inc.
-
Trinity Capital Inc. Announces Adjustment to Conversion Rate of its 6.00% Convertible Notes due 2025
-
Trinity Capital Inc. Prices Offering of $100.0 Million of 7.875% Notes due 2029
-
Trinity Capital Inc. Increases Cash Dividend to $0.51 per Share for the First Quarter of 2024
-
Trinity Capital Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
-
Trinity Capital Inc. Provides $50 Million in Equipment Financing to Electric Hydrogen
-
Trinity Capital Inc. Provides $25 Million Growth Capital to Moxe Health
-
Trinity Capital Inc. Provides $120 Million Equipment Financing to Rocket Lab
-
Trinity Capital Inc. Provides $20 Million Equipment Financing to Formlogic
-
Trinity Capital Inc. Confirms Fourth Quarter 2023 Call and Announces 2024 Financial Reporting Dates
-
Trinity Capital Receives Investment Grade Rating from Morningstar DBRS
-
Trinity Capital Inc. Provides $15 Million Venture Debt Facility to Kafene
-
Trinity Capital Inc. Further Expands East Coast Presence with Appointment of Brendan Carr as Director
-
Trinity Capital Inc. Originates $831 Million in New Commitments in 2023
-
Trinity Capital Inc. Appoints Michael Testa as Chief Financial Officer
-
Trinity Capital Inc. Announces Adjustment to Conversion Rate of its 6.00% Convertible Notes due 2025
-
Trinity Capital Inc. Provides $30 Million Growth Capital to Cart.com
-
Trinity Capital Inc. Announces Phoenix Headquarters Expansion, Highlighting Company's Continued Growth and Success
-
Trinity Capital Inc. Provides $40 Million Term Loan to Taysha Gene Therapies
-
Trinity Capital Inc. Continues Life Sciences Growth, Hires Industry Veteran Ryan Kaeding as Managing Director
-
Trinity Capital Inc. Declares Cash Dividend of $0.50 per Share for the Fourth Quarter of 2023
-
Trinity Capital Inc. Provides $45 Million Growth Capital to Neurolens
-
Trinity Capital Inc. Reports Third Quarter 2023 Financial Results
-
Trinity Capital Inc. Provides $25 Million Growth Capital to Neuros Medical, Inc.
-
Trinity Capital Inc. to Participate in the Jefferies 8th Annual BDC Summit
-
Trinity Capital Inc. Provides Details for Third Quarter 2023 Financial Results and Conference Call
-
Trinity Capital Inc. Announces Adjustment to Conversion Rate of its 6.00% Convertible Notes due 2025
-
Trinity Capital Inc. to Participate in KBW BDC Midtown March
-
Trinity Capital Inc. Declares Cash Dividend of $0.54 per Share for the Third Quarter of 2023, Including a Supplemental Cash Dividend of $0.05 per Share
-
Trinity Capital Inc. Announces CEO Transition: Steve Brown to Assume Role of Executive Chairman, Kyle Brown Named CEO, Effective January 2024
-
Trinity Capital Inc. Provides $12 Million Growth Capital to Delphinus Medical Technologies, Inc.
-
Trinity Capital Inc. Provides $20 Million Growth Capital to MacroFab
-
Trinity Capital Inc. Announces Pricing of $75.0 Million of Shares of Common Stock
-
Trinity Capital Inc. Announces Offering of $75.0 Million of Shares of Common Stock
-
Trinity Capital Inc. Reports Second Quarter 2023 Financial Results
-
Trinity Capital Inc. Announces Time Change for its Second Quarter 2023 Conference Call
-
Trinity Capital Inc. Provides Details for Second Quarter 2023 Financial Results and Conference Call
-
Trinity Capital Inc. Announces Adjustment to Conversion Rate of its 6.00% Convertible Notes due 2025
-
Trinity Capital Inc. Expands East Coast Presence with Appointment of Andrew Ghannam as Managing Director
-
Trinity Capital Inc. Expands its Life Sciences Vertical
-
Trinity Capital Inc. Declares Cash Dividend of $0.53 per Share for the Second Quarter of 2023, Including a Supplemental Cash Dividend of $0.05 per Share
-
Trinity Capital Inc. Provides $30 Million Growth Capital to Revelle Aesthetics
-
Trinity Capital Inc. Reports First Quarter 2023 Financial Results
-
Trinity Capital Inc. Provides $40 Million Growth Capital to Convergent Dental, Inc.
-
Trinity Capital Inc. Announces Time Change for its First Quarter 2023 Conference Call
-
Trinity Capital Inc. Provides Details for First Quarter 2023 Financial Results and Conference Call
-
Trinity Capital Inc. Announces Adjustment to Conversion Rate of its 6.00% Convertible Notes due 2025
-
Trinity Capital Inc. Declares Cash Dividend Increase to $0.47 per Share and Provides Business Update
-
Trinity Capital Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
Back to TRIN Stock Lookup